Baldwin Wealth Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.81M | Sell |
|
|||||
|
2025
Q2 | $12.5M | Buy |
|
|||||
|
2025
Q1 | $11.8M | Buy |
|
|||||
|
2024
Q4 | $4.19M | Sell |
|
|||||
|
2024
Q3 | $6.58M | Buy |
|
|||||
|
2024
Q2 | $6.96M | Sell |
|
|||||
|
2024
Q1 | $6.28M | Sell |
|
|||||
|
2023
Q4 | $5.18M | Sell |
|
|||||
|
2023
Q3 | $4.92M | Buy |
|
|||||
|
2023
Q2 | $4.38M | Sell |
|
|||||
|
2023
Q1 | $4.32M | Sell |
|
|||||
|
2022
Q4 | $3.69M | Buy |
|
|||||
|
2022
Q3 | $271K | Sell |
|
|||||
|
2022
Q2 | $306K | Sell |
|
|||||
|
2022
Q1 | $309K | Sell |
|
|||||
|
2021
Q4 | $324K | Buy |
|
|||||
|
2021
Q3 | $263K | Sell |
|
|||||
|
2021
Q2 | $234K | Sell |
|
|||||
|
2021
Q1 | $194K | Sell |
|
|||||
|
2020
Q4 | $236K | Sell |
|
|||||
|
2020
Q3 | $240K | Sell |
|
|||||
|
2020
Q2 | $227K | Sell |
|
|||||
|
2020
Q1 | $222K | Sell |
|
|||||
|
2019
Q4 | $251K | Buy |
|
|||||
|
2019
Q3 | $171K | Sell |
|
|||||
|
2019
Q2 | $844K | Sell |
|
|||||
|
2019
Q1 | $1.06M | Hold |
|
|||||
|
2018
Q4 | $933K | Hold |
|
|||||
|
2018
Q3 | $954K | Sell |
|
|||||
|
2018
Q2 | $997K | Hold |
|
|||||
|
2018
Q1 | $1.06M | Sell |
|
|||||
|
2017
Q4 | $1.17M | Buy |
|
|||||
|
2017
Q3 | $1.01M | Hold |
|
|||||
|
2017
Q2 | $904K | Sell |
|
|||||
|
2017
Q1 | $752K | Buy |
|
|||||
|
2016
Q4 | $508K | Buy |
|
|||||
|
2016
Q3 | $151K | Sell |
|
|||||
|
2016
Q2 | $275K | Buy |
|
|||||
|
2016
Q1 | $267K | Buy |
|
|||||
|
2015
Q4 | $272K | Sell |
|
|||||
|
2015
Q3 | $256K | Sell |
|
|||||
|
2015
Q2 | $300K | Hold |
|
|||||
|
2015
Q1 | $292K | Sell |
|
|||||
|
2014
Q4 | $252K | Sell |
|
|||||
|
2014
Q3 | $290K | Sell |
|
|||||
|
2014
Q2 | $534K | Buy |
|
|||||
|
2014
Q1 | $375K | Buy |
|
|||||
|
2013
Q4 | $270K | Buy |
|
|||||
|
2013
Q3 | $210K | Sell |
|
|||||
|
2013
Q2 | $315K | Buy |
|